Skip to main content
Top
Published in: Cellular Oncology 4/2011

01-08-2011 | Original Paper

Automated analysis of protein expression and gene amplification within the same cells of paraffin-embedded tumour tissue

Authors: Timo Gaiser, Lissa Berroa-Garcia, Ralf Kemmerling, Aparajita Dutta, Thomas Ried, Kerstin Heselmeyer-Haddad

Published in: Cellular Oncology | Issue 4/2011

Login to get access

Abstract

Background

The simultaneous detection of protein expression and gene copy number changes in patient samples, like paraffin-embedded tissue sections, is challenging since the procedures of immunohistochemistry (IHC) and Fluorescence in situ Hybridization (FISH) negatively influence each other which often results in suboptimal staining. Therefore, we developed a novel automated algorithm based on relocation which allows subsequent detection of protein content and gene copy number changes within the same cell.

Methods

Paraffin-embedded tissue sections of colorectal cancers were stained for CD133 expression. IHC images were acquired and image coordinates recorded. Slides were subsequently hybridized with fluorescently labeled DNA probes. FISH images were taken at the previously recorded positions allowing for direct comparison of protein expression and gene copy number signals within the same cells/tissue areas. Relocation, acquisition of the IHC and FISH images, and enumeration of FISH signals in the immunophenotyped tumour areas were done in an automated fashion.

Results

Automated FISH analysis was performed on 13 different colon cancer samples that had been stained for CD133; each sample was scored for MYC, ZNF217 and Chromosome 6 in CD133 positive and negative glands. From the 13 cases four (31%) showed amplification for the MYC oncogene and seven of 13 (54%) cases were amplified for ZNF217. There was no significant difference between CD133 positive tumour and CD133 negative tumour cells.

Conclusion

The technique and algorithm presented here enables an easy and reproducible combination of IHC and FISH based on a novel automated algorithm using relocation and automated spot counting.
Literature
1.
go back to reference N.A. Jambhekar, A.C. Chaturvedi, B.P. Madur, Immunohistochemistry in surgical pathology practice: a current perspective of a simple, powerful, yet complex, tool. Indian J Pathol Microbiol 51, 2–11 (2008)PubMedCrossRef N.A. Jambhekar, A.C. Chaturvedi, B.P. Madur, Immunohistochemistry in surgical pathology practice: a current perspective of a simple, powerful, yet complex, tool. Indian J Pathol Microbiol 51, 2–11 (2008)PubMedCrossRef
2.
go back to reference A. Bressenot, S. Marchal, L. Bezdetnaya, J. Garrier, F. Guillemin, F. Plenat, Assessment of apoptosis by immunohistochemistry to active caspase-3, active caspase-7, or cleaved PARP in monolayer cells and spheroid and subcutaneous xenografts of human carcinoma. J Histochem Cytochem 57, 289–300 (2009)PubMedCrossRef A. Bressenot, S. Marchal, L. Bezdetnaya, J. Garrier, F. Guillemin, F. Plenat, Assessment of apoptosis by immunohistochemistry to active caspase-3, active caspase-7, or cleaved PARP in monolayer cells and spheroid and subcutaneous xenografts of human carcinoma. J Histochem Cytochem 57, 289–300 (2009)PubMedCrossRef
3.
go back to reference M.V. Rojiani, D.W. Siemann, A.M. Rojiani, Appl. Immunohistochem. Mol. Morphol. Cell proliferation index determination by immunohistochemical detection of hCDC47 Protein (2009) M.V. Rojiani, D.W. Siemann, A.M. Rojiani, Appl. Immunohistochem. Mol. Morphol. Cell proliferation index determination by immunohistochemical detection of hCDC47 Protein (2009)
4.
go back to reference R. Moll, M. Divo, L. Langbein, The human keratins: biology and pathology. Histochem Cell Biol 129, 705–733 (2008)PubMedCrossRef R. Moll, M. Divo, L. Langbein, The human keratins: biology and pathology. Histochem Cell Biol 129, 705–733 (2008)PubMedCrossRef
5.
go back to reference M.G. Tibiletti, B. Bernasconi, A. Dionigi, C. Riva, The applications of FISH in tumor pathology. Adv Clin Path 3, 111–118 (1999)PubMed M.G. Tibiletti, B. Bernasconi, A. Dionigi, C. Riva, The applications of FISH in tumor pathology. Adv Clin Path 3, 111–118 (1999)PubMed
6.
go back to reference C. Donadoni, S. Corti, F. Locatelli, D. Papadimitriou, M. Guglieri, S. Strazzer, P. Bossolasco, S. Salani, G.P. Comi, Improvement of combined FISH and immunofluorescence to trace the fate of somatic stem cells after transplantation. J Histochem Cytochem 52, 1333–1339 (2004)PubMed C. Donadoni, S. Corti, F. Locatelli, D. Papadimitriou, M. Guglieri, S. Strazzer, P. Bossolasco, S. Salani, G.P. Comi, Improvement of combined FISH and immunofluorescence to trace the fate of somatic stem cells after transplantation. J Histochem Cytochem 52, 1333–1339 (2004)PubMed
7.
go back to reference K. Khosrotehrani, H. Stroh, D.W. Bianchi, K.L. Johnson, Combined FISH and immunolabeling on paraffin-embedded tissue sections for the study of microchimerism. Biotechniques 34, 242–244 (2003)PubMed K. Khosrotehrani, H. Stroh, D.W. Bianchi, K.L. Johnson, Combined FISH and immunolabeling on paraffin-embedded tissue sections for the study of microchimerism. Biotechniques 34, 242–244 (2003)PubMed
8.
go back to reference Loerch T, Piper J, Tomisek JD (2002) “Tile sampling”: a new method for the automated quantitative analyses of samples with high cell density and its application to Her2 scanning. Proceedings of the Third Euroconference on Quantitative Molecular Cytogenetics, Rosenön, Stockholm, Sweden, July 4–6 2002, 9–14 Loerch T, Piper J, Tomisek JD (2002) “Tile sampling”: a new method for the automated quantitative analyses of samples with high cell density and its application to Her2 scanning. Proceedings of the Third Euroconference on Quantitative Molecular Cytogenetics, Rosenön, Stockholm, Sweden, July 4–6 2002, 9–14
9.
go back to reference Piper J, Loerch T, Poole I, Tomisek JD (2002) Computing the Her2:CEP-17 ratio of tumour cells in breast cancer tissue sections by analysis of the FISH spot counts of a tiles sampling. Proceedings of the Third Euroconference on Quantitative Molecular Cytogenetics, Rosenön, Stockholm, Sweden, July 4–6 2002, 54–59. Piper J, Loerch T, Poole I, Tomisek JD (2002) Computing the Her2:CEP-17 ratio of tumour cells in breast cancer tissue sections by analysis of the FISH spot counts of a tiles sampling. Proceedings of the Third Euroconference on Quantitative Molecular Cytogenetics, Rosenön, Stockholm, Sweden, July 4–6 2002, 54–59.
10.
go back to reference J. Camps, M. Grade, Q.T. Nguyen, P. Hormann, S. Becker, A.B. Hummon, V. Rodriguez, S. Chandrasekharappa, Y. Chen, M.J. Difilippantonio, H. Becker, B.M. Ghadimi, T. Ried, Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genome. Cancer Res 68, 1284–1295 (2008)PubMedCrossRef J. Camps, M. Grade, Q.T. Nguyen, P. Hormann, S. Becker, A.B. Hummon, V. Rodriguez, S. Chandrasekharappa, Y. Chen, M.J. Difilippantonio, H. Becker, B.M. Ghadimi, T. Ried, Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genome. Cancer Res 68, 1284–1295 (2008)PubMedCrossRef
11.
go back to reference G.A. Meijer, M.A. Hermsen, J.P. Baak, P.J. van Diest, S.G. Meuwissen, J.A. Belien, J.M. Hoovers, H. Joenje, P.J. Snijders, J.M. Walboomers, Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. J Clin Pathol 51, 901–909 (1998)PubMedCrossRef G.A. Meijer, M.A. Hermsen, J.P. Baak, P.J. van Diest, S.G. Meuwissen, J.A. Belien, J.M. Hoovers, H. Joenje, P.J. Snijders, J.M. Walboomers, Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. J Clin Pathol 51, 901–909 (1998)PubMedCrossRef
12.
go back to reference T. Ried, R. Knutzen, R. Steinbeck, H. Blegen, E. Schrock, K. Heselmeyer, S. du Manoir, G. Auer, Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 15, 234–245 (1996)PubMedCrossRef T. Ried, R. Knutzen, R. Steinbeck, H. Blegen, E. Schrock, K. Heselmeyer, S. du Manoir, G. Auer, Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 15, 234–245 (1996)PubMedCrossRef
13.
go back to reference K. Al-Kuraya, H. Novotny, P. Bavi, A.K. Siraj, S. Uddin, A. Ezzat, N.A. Sanea, F. Al-Dayel, H. Al-Mana, S.S. Sheikh, M. Mirlacher, C. Tapia, R. Simon, G. Sauter, L. Terracciano, L. Tornillo, HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer. J Clin Pathol 60, 768–772 (2007)PubMedCrossRef K. Al-Kuraya, H. Novotny, P. Bavi, A.K. Siraj, S. Uddin, A. Ezzat, N.A. Sanea, F. Al-Dayel, H. Al-Mana, S.S. Sheikh, M. Mirlacher, C. Tapia, R. Simon, G. Sauter, L. Terracciano, L. Tornillo, HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer. J Clin Pathol 60, 768–772 (2007)PubMedCrossRef
14.
go back to reference P.H. Rooney, A. Boonsong, M.C. McFadyen, H.L. McLeod, J. Cassidy, S. Curran, G.I. Murray, The candidate oncogene ZNF217 is frequently amplified in colon cancer. J Pathol 204, 282–288 (2004)PubMedCrossRef P.H. Rooney, A. Boonsong, M.C. McFadyen, H.L. McLeod, J. Cassidy, S. Curran, G.I. Murray, The candidate oncogene ZNF217 is frequently amplified in colon cancer. J Pathol 204, 282–288 (2004)PubMedCrossRef
15.
go back to reference C. Postma, M.A. Hermsen, J. Coffa, J.P. Baak, J.D. Mueller, E. Mueller, B. Bethke, J.P. Schouten, M. Stolte, G.A. Meijer, Chromosomal instability in flat adenomas and carcinomas of the colon. J Pathol 205, 514–521 (2005)PubMedCrossRef C. Postma, M.A. Hermsen, J. Coffa, J.P. Baak, J.D. Mueller, E. Mueller, B. Bethke, J.P. Schouten, M. Stolte, G.A. Meijer, Chromosomal instability in flat adenomas and carcinomas of the colon. J Pathol 205, 514–521 (2005)PubMedCrossRef
16.
go back to reference C.A. O’Brien, A. Pollett, S. Gallinger, J.E. Dick, A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106–110 (2007)PubMedCrossRef C.A. O’Brien, A. Pollett, S. Gallinger, J.E. Dick, A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106–110 (2007)PubMedCrossRef
17.
go back to reference L. Ricci-Vitiani, D.G. Lombardi, E. Pilozzi, M. Biffoni, M. Todaro, C. Peschle, R. De Maria, Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111–115 (2007)PubMedCrossRef L. Ricci-Vitiani, D.G. Lombardi, E. Pilozzi, M. Biffoni, M. Todaro, C. Peschle, R. De Maria, Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111–115 (2007)PubMedCrossRef
18.
go back to reference C. Lottner, S. Schwarz, S. Diermeier, A. Hartmann, R. Knuechel, F. Hofstaedter, G. Brockhoff, Simultaneous detection of HER2/neu gene amplification and protein overexpression in paraffin-embedded breast cancer. J Pathol 205, 577–584 (2005)PubMedCrossRef C. Lottner, S. Schwarz, S. Diermeier, A. Hartmann, R. Knuechel, F. Hofstaedter, G. Brockhoff, Simultaneous detection of HER2/neu gene amplification and protein overexpression in paraffin-embedded breast cancer. J Pathol 205, 577–584 (2005)PubMedCrossRef
19.
go back to reference L.D. Cooley, J.T. Mascarello, B. Hirsch, P.B. Jacky, P.N. Rao, D. Saxe, K.W. Rao, Section E6.5 of the ACMG technical standards and guidelines: chromosome studies for solid tumor abnormalities. Genet Med 11, 890–897 (2009)PubMedCrossRef L.D. Cooley, J.T. Mascarello, B. Hirsch, P.B. Jacky, P.N. Rao, D. Saxe, K.W. Rao, Section E6.5 of the ACMG technical standards and guidelines: chromosome studies for solid tumor abnormalities. Genet Med 11, 890–897 (2009)PubMedCrossRef
20.
go back to reference M. Bilous, M. Dowsett, W. Hanna, J. Isola, A. Lebeau, A. Moreno, F. Penault-Llorca, J. Ruschoff, G. Tomasic, M. van de Vijver, Current perspectives on HER2 testing: a review of national testing guidelines. Mod Pathol 16, 173–182 (2003)PubMedCrossRef M. Bilous, M. Dowsett, W. Hanna, J. Isola, A. Lebeau, A. Moreno, F. Penault-Llorca, J. Ruschoff, G. Tomasic, M. van de Vijver, Current perspectives on HER2 testing: a review of national testing guidelines. Mod Pathol 16, 173–182 (2003)PubMedCrossRef
21.
go back to reference M. Hofmann, O. Stoss, T. Gaiser, H. Kneitz, P. Heinmoller, T. Gutjahr, M. Kaufmann, T. Henkel, J. Ruschoff, Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomy. J Clin Pathol 61, 89–94 (2008)PubMedCrossRef M. Hofmann, O. Stoss, T. Gaiser, H. Kneitz, P. Heinmoller, T. Gutjahr, M. Kaufmann, T. Henkel, J. Ruschoff, Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomy. J Clin Pathol 61, 89–94 (2008)PubMedCrossRef
22.
go back to reference G. Sauter, J. Lee, J.M. Bartlett, D.J. Slamon, M.F. Press, Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations. J Clin Oncol 27, 1323–1333 (2009)PubMedCrossRef G. Sauter, J. Lee, J.M. Bartlett, D.J. Slamon, M.F. Press, Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations. J Clin Oncol 27, 1323–1333 (2009)PubMedCrossRef
23.
go back to reference A.C. Wolff, M.E. Hammond, J.N. Schwartz, K.L. Hagerty, D.C. Allred, R.J. Cote, M. Dowsett, P.L. Fitzgibbons, W.M. Hanna, A. Langer, L.M. McShane, S. Paik, M.D. Pegram, E.A. Perez, M.F. Press, A. Rhodes, C. Sturgeon, S.E. Taube, R. Tubbs, G.H. Vance, M. van de Vijver, T.M. Wheeler, D.F. Hayes, American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 131, 18–43 (2007)PubMed A.C. Wolff, M.E. Hammond, J.N. Schwartz, K.L. Hagerty, D.C. Allred, R.J. Cote, M. Dowsett, P.L. Fitzgibbons, W.M. Hanna, A. Langer, L.M. McShane, S. Paik, M.D. Pegram, E.A. Perez, M.F. Press, A. Rhodes, C. Sturgeon, S.E. Taube, R. Tubbs, G.H. Vance, M. van de Vijver, T.M. Wheeler, D.F. Hayes, American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 131, 18–43 (2007)PubMed
24.
go back to reference M. Brunelli, E. Manfrin, G. Martignoni, K. Miller, A. Remo, D. Reghellin, S. Bersani, S. Gobbo, A. Eccher, M. Chilosi, F. Bonetti, Genotypic intratumoral heterogeneity in breast carcinoma with HER2/neu amplification: evaluation according to ASCO/CAP criteria. Am J Clin Pathol 131, 678–682 (2009)PubMedCrossRef M. Brunelli, E. Manfrin, G. Martignoni, K. Miller, A. Remo, D. Reghellin, S. Bersani, S. Gobbo, A. Eccher, M. Chilosi, F. Bonetti, Genotypic intratumoral heterogeneity in breast carcinoma with HER2/neu amplification: evaluation according to ASCO/CAP criteria. Am J Clin Pathol 131, 678–682 (2009)PubMedCrossRef
25.
go back to reference G.H. Vance, T.S. Barry, K.J. Bloom, P.L. Fitzgibbons, D.G. Hicks, R.B. Jenkins, D.L. Persons, R.R. Tubbs, M.E. Hammond, Genetic heterogeneity in HER2 testing in breast cancer: panel summary and guidelines. Arch Pathol Lab Med 133, 611–612 (2009)PubMed G.H. Vance, T.S. Barry, K.J. Bloom, P.L. Fitzgibbons, D.G. Hicks, R.B. Jenkins, D.L. Persons, R.R. Tubbs, M.E. Hammond, Genetic heterogeneity in HER2 testing in breast cancer: panel summary and guidelines. Arch Pathol Lab Med 133, 611–612 (2009)PubMed
26.
go back to reference C.B. Moelans, R.A. de Weger, M.T. van Blokland, C. Ezendam, S. Elshof, M.G. Tilanus, P.J. van Diest, HER-2/neu amplification testing in breast cancer by multiplex ligation-dependent probe amplification in comparison with immunohistochemistry and in situ hybridization. Cell Oncol 31, 1–10 (2009)PubMed C.B. Moelans, R.A. de Weger, M.T. van Blokland, C. Ezendam, S. Elshof, M.G. Tilanus, P.J. van Diest, HER-2/neu amplification testing in breast cancer by multiplex ligation-dependent probe amplification in comparison with immunohistochemistry and in situ hybridization. Cell Oncol 31, 1–10 (2009)PubMed
Metadata
Title
Automated analysis of protein expression and gene amplification within the same cells of paraffin-embedded tumour tissue
Authors
Timo Gaiser
Lissa Berroa-Garcia
Ralf Kemmerling
Aparajita Dutta
Thomas Ried
Kerstin Heselmeyer-Haddad
Publication date
01-08-2011
Publisher
Springer Netherlands
Published in
Cellular Oncology / Issue 4/2011
Print ISSN: 2211-3428
Electronic ISSN: 2211-3436
DOI
https://doi.org/10.1007/s13402-011-0032-x

Other articles of this Issue 4/2011

Cellular Oncology 4/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine